StonvexLoading…
StonvexStonvexStonvexCore line items from CLFD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $150.13M | $125.57M | $225.72M | $270.88M |
Operating Income | $2.12M | $-19.23M | $37.58M | $63.82M |
Net Income | $-8.05M | $-12.45M | $32.53M | $49.36M |
EPS (Diluted) | $-0.58 | $-0.85 | $2.17 | $3.55 |
Total Assets | $306.17M | $315.27M | $355.52M | $229.13M |
Total Liabilities | $50.01M | $39.51M | $40.35M | $81.55M |
Cash & Equivalents | $21.49M | $14.15M | $37.83M | $16.65M |
Free Cash Flow OCF − CapEx | $21.81M | $12.66M | $10.74M | $-6.24M |
Shares Outstanding | 13.84M | 14.23M | 15.25M | 13.82M |